Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs
Authors:
- Martin AchleitnerMAMartin Achleitner
- Martin KleefischMKMartin Kleefisch
- Alexander HennigAHAlexander Hennig
- Anastasia PolikarpovaAPAnastasia Polikarpova
- Reinhard OertelROReinhard Oertel
- Benjamin GabrielBGBenjamin Gabriel
- Livia SchulzeLSLivia Schulze
- Dirk LindemanDLDirk Lindeman
- Alexander GerbauletAGAlexander Gerbaulet
- Min Ae Lee-KirschMLMin Ae Lee-Kirsch
Open Access
- 1 October 2017
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 199 (7) , 2261-2269
Abstract
Biallelic mutations of three prime repair exonuclease 1 (TREX1) cause the lupus-like disease Aicardi–Goutières syndrome in which accumulation of a yet unknown endogenous DNA substrate of TREX1 triggers a cyclic GMP–AMP synthase-dependent type I IFN response and systemic autoimmunity. Products of reverse transcription originating from endogenous retroelements have been suggested to be a major substrate for TREX1, and reverse transcriptase inhibitors (RTIs) were proposed as a therapeutic option in autoimmunity ensuing from defects of TREX1. In this study, we treated Trex1−/− mice with RTIs. The serum RTI levels reached were sufficient to block retrotransposition of endogenous retroelements. However, the treatment did not reduce the spontaneous type I IFN response and did not ameliorate lethal inflammation. Furthermore, long interspersed nuclear elements 1 retrotransposition was not enhanced in the absence of Trex1. Our data do not support the concept of retroelement-derived cDNA as key triggers of systemic autoimmunity in Trex1-deficient humans and mice and motivate the continuing search for the pathogenic IFN-inducing Trex1 substrate.Keywords
This publication has 60 references indexed in Scilit:
- Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overviewJournal of Experimental Medicine, 2016
- Aicardi–Goutières syndrome and the type I interferonopathiesNature Reviews Immunology, 2015
- Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1American Journal of Medical Genetics Part A, 2015
- Aicardi-Goutières Syndrome Is Caused by IFIH1 MutationsThe American Journal of Human Genetics, 2014
- Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signalingNature Genetics, 2014
- Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signatureNature Genetics, 2012
- Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune responseNature Genetics, 2009
- Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosusNature Genetics, 2007
- Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locusNature Genetics, 2006
- Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infectionNature Genetics, 2006